SBC Medical Group Holdings Inc 8-K

What Happened

• SBC Medical Group Holdings Inc. announced an underwritten offering on April 19, 2026. The offering involved 3,100,000 shares of the company’s common stock being sold by the company’s CEO and chairman, Dr. Yoshiyuki Aikawa, under a Registration Statement on Form S-3 (File No. 333-292451, filed Dec. 29, 2025). Maxim Group LLC served as representative of the underwriters. The underwriters have a 45-day option to purchase up to an additional 465,000 shares. The offering closed on April 21, 2026. The company did not sell any shares in the offering and received no proceeds.

Key Details

• Offering size: 3,100,000 shares by the selling stockholder (Dr. Yoshiyuki Aikawa).
• Underwriters’ option: 45-day option to buy up to 465,000 additional shares.
• Dates: Underwriting Agreement dated April 19, 2026; offering closed April 21, 2026.
• Company impact: SBC did not issue shares or receive any cash from the transaction.

Why It Matters

• This was a secondary sale by an insider (the CEO and chairman), not a capital raise by the company, so there was no immediate cash benefit to SBC.
• The transaction increases the number of shares available for public trading (if sold by the insider), which can affect supply and potentially pressure the stock price; the underwriters’ option could further increase that potential supply.
• Investors should note insider selling activity and monitor any filings showing how many shares the selling stockholder ultimately sold and whether the underwriters exercised their option.